Cancer
Studies conducted at Washington University, Medical Department on cancer recently published
Published in Blood Weekly, August 28th, 2008
In this recent article published in the Journal of Thoracic Oncology, scientists in the United States conducted a study "To determine the prognostic value of celiac lymphadenopathy for patients with esophageal or gastroesophageal junction carcinomas treated with neoadjuvant or definitive chemoradiotherapy. The records of patients undergoing chemoradiation therapy for esophageal cancer, who received a dose of at least 45 Gy, were retrospectively reviewed."
"One hundred forty-four patients were eligible for this retrospective analysis; 99 had MO and 45 M1a disease. The median radiation dose was 50.4 Gy for patients receiving both neoadjuvant and definitive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-08-28)
More Articles from Blood Weekly
- New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
N.Y. research team discovers how antidepressants and cocaine interact with brain cell targets - Autoimmune Hemolytic Anemia
Studies from M. Gentile et al in the area of autoimmune hemolytic anemia described - Biologics
The third generation of TPO mimetics are again biologics - Blood Components
Studies from University of Texas further understanding of blood components - Cancer
EntreMed Teams with JSB-Partners to Expedite Partnering of its Aurora Kinase Program - Cancer
Scientists at University of Texas detail research in cancer - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
